Lipocine Inc. (LPCN)

Trade Setup

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability.

Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day.   The stocks are starting new uptrends and have buy signals.  These are high reward to risk stocks with the potential for very sharp moves.  A stop should be maintained at the low of the most recent hold signal day.   Target prices for exits can be determined by using the next level of resistance higher or by using Fibonacci resistance levels found using TradersPro. Trailing stops or letting the stock run until the next sell signal is also a sell strategy.

X